Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Neurology · Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

How Does CADASIL Stroke Differ From Atherosclerotic Stroke?

At a Glance

A CADASIL stroke usually results from NOTCH3-related damage to tiny blood vessels deep in the brain, while an atherosclerotic stroke usually involves plaque and clot in larger arteries. Both require immediate emergency evaluation, but prevention may differ.

To understand why CADASIL requires a specific approach to management, it helps to look at what happens inside the blood vessels. Strokes broadly fall into two categories: ischemic (caused by interrupted blood flow) and hemorrhagic (caused by a ruptured vessel bleeding into the brain). While CADASIL is most known for causing small ischemic strokes, it can also increase the risk of hemorrhagic strokes [1].

When comparing a CADASIL-related ischemic stroke to a conventional ischemic stroke, the underlying causes are fundamentally different.

A non-CADASIL ischemic stroke is often described as a “plumbing” problem. While there are many potential causes (such as blood clots traveling from the heart), one of the most common is atherosclerosis—a condition where cholesterol, fats, and other substances build up as lipid-rich plaques inside large or medium-sized arteries [2]. Over time, these plaques can rupture or cause a clot, blocking the vessel and starving the brain of oxygen [2].

A CADASIL ischemic stroke, however, is a structural “hardware” problem affecting the very small blood vessels deep inside the brain [2]. Because of the mutated NOTCH3 gene, the smooth muscle cells that make up the walls of these tiny vessels are damaged [3]. Abnormal protein deposits build up around these cells, causing the vessel walls to become thick, stiff, and scarred [3][4]. Rather than a cholesterol plaque blocking the inside of the pipe, the damaged vessel loses its ability to widen and narrow properly [4]. This impairs blood flow regulation and can eventually lead to a chronic lack of blood flow and small strokes (lacunar infarcts) [4][5].

Emergency Care is Still Standard

When to Seek Emergency Help
Even with a known CADASIL diagnosis, any sudden weakness, numbness, speech difficulty, vision loss, severe imbalance, or sudden severe headache requires immediate emergency care (call 911 or your local emergency number). Emergency assessment is the only way to determine if a stroke is ischemic or hemorrhagic and to see if time-sensitive, life-saving treatments can be used.

Why Preventive Treatments May Differ

Because the root cause of a CADASIL stroke is different from an atherosclerotic stroke, some long-term prevention strategies differ [6].

For a conventional stroke caused by plaque buildup, doctors often prescribe high-intensity statin medications. Statins lower cholesterol and stabilize plaques, directly treating the “plumbing” issue [6]. However, because CADASIL is caused by structural damage to the vessel wall rather than cholesterol buildup, statins do not reverse or slow down the underlying NOTCH3 disease process [7]. There is currently no evidence showing that statins prevent strokes caused specifically by CADASIL [7].

Comparison Table

Feature Conventional Atherosclerotic Stroke CADASIL-Related Stroke
Primary Cause Plaque buildup (cholesterol/fats) blocking the vessel [2] NOTCH3 mutation damaging the vessel wall structure [2]
Vessels Affected Usually large to medium-sized arteries [2] Small penetrating blood vessels deep in the brain [2]
Statin Effect Slows plaque growth and stabilizes vessels [6] Does not reverse the underlying NOTCH3 damage [7]
Acute Treatment Emergency evaluation required Emergency evaluation required

Managing Both Conditions

Even though statins do not fix the structural damage caused by CADASIL, you should never stop taking a prescribed statin or blood pressure medication without consulting your doctor. A person can have CADASIL and also develop traditional atherosclerosis or heart disease [8]. If you have high cholesterol or a history of heart disease, statins may still be highly beneficial for your overall cardiovascular health [9].

Because CADASIL alters your brain’s small vessels, managing standard cardiovascular risk factors remains a critical part of your care [8]. Controlling blood pressure is especially vital; studies show that hypertension combined with the NOTCH3 mutation increases the risk of bleeding in the brain [1]. While there is no cure yet for the “hardware” issue of CADASIL, working with your doctor to maintain a safe, individualized blood pressure target and a healthy lifestyle helps protect your brain from further damage.

Common questions in this guide

What causes a CADASIL stroke compared with an atherosclerotic stroke?
A CADASIL stroke usually results from a NOTCH3 mutation that damages the walls of tiny penetrating blood vessels deep in the brain. An atherosclerotic stroke usually happens when cholesterol-rich plaque in a larger or medium-sized artery narrows the vessel or triggers a clot that blocks blood flow.
Are CADASIL strokes always ischemic?
CADASIL is best known for causing small ischemic strokes, often called lacunar infarcts, but it can also raise the risk of bleeding in the brain. Because the symptoms can overlap, sudden weakness, numbness, speech trouble, vision loss, severe imbalance, or a severe headache needs emergency evaluation.
Should I call emergency services for stroke symptoms if I already have CADASIL?
Yes. Any sudden weakness, numbness, speech difficulty, vision loss, severe imbalance, or sudden severe headache requires immediate emergency help, because only urgent assessment can show whether the stroke is ischemic or hemorrhagic and whether time-sensitive treatment may help.
Do statins prevent strokes caused by CADASIL?
Statins lower cholesterol and help stabilize atherosclerotic plaque, but they do not reverse the blood-vessel damage caused by the NOTCH3 mutation. There is no evidence that statins specifically prevent CADASIL-related strokes, although they may still be appropriate for high cholesterol, atherosclerosis, or heart disease; do not stop a prescribed statin without medical advice.
Why is blood pressure control important with CADASIL?
Keeping blood pressure within an individualized range is an important part of CADASIL care. Hypertension combined with the NOTCH3 mutation can increase the risk of bleeding in the brain, so medication changes and blood-pressure targets should be discussed with a clinician.
Can someone with CADASIL also have a stroke from plaque buildup?
Yes. CADASIL and traditional atherosclerosis or heart disease can occur in the same person, so cholesterol, blood pressure, and other cardiovascular risks still need appropriate management. A clinician can help determine whether a statin or other preventive medicine is being used for those additional risks.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What evidence shows that my recent symptoms were caused by CADASIL rather than another mechanism like a heart rhythm issue or traditional plaque?
  2. 2.If I am taking a statin, is it to manage my overall heart risk and cholesterol, and are there specific targets we are trying to hit?
  3. 3.What is my ideal, individualized blood pressure target, and how can we safely maintain it without dropping it too low?
  4. 4.Should we discuss modifying my antiplatelet or blood-thinning medications based on my history and any microbleeds seen on my MRI?
  5. 5.Given my diagnosis, how frequently should we be monitoring my blood pressure and cholesterol levels?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?

    Chen CH, Cheng YW, Zhang R, et al.

    Stroke 2025; (56(8)):2159-2166 doi:10.1161/STROKEAHA.124.050484.

    PMID: 40270244
  2. 2

    CADASIL: A NOTCH3-associated cerebral small vessel disease.

    Yuan L, Chen X, Jankovic J, Deng H

    Journal of advanced research 2024; (66()):223-235 doi:10.1016/j.jare.2024.01.001.

    PMID: 38176524
  3. 3

    Signaling pathways and molecular mechanisms involved in the onset and progression of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); a focus on Notch3 signaling.

    Heidari P, Taghizadeh M, Vakili O

    The journal of headache and pain 2025; (26(1)):96 doi:10.1186/s10194-025-02025-z.

    PMID: 40301727
  4. 4

    ER stress and Rho kinase activation underlie the vasculopathy of CADASIL.

    Neves KB, Harvey AP, Moreton F, et al.

    JCI insight 2019; (4(23)).

    PMID: 31647781
  5. 5

    Mechanistic advances in factors influencing phenotypic variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a review.

    Zhao Y, Lu Y, Wang F, et al.

    Frontiers in neurology 2025; (16()):1573052 doi:10.3389/fneur.2025.1573052.

    PMID: 40470487
  6. 6

    Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association.

    Meschia JF, Worrall BB, Elahi FM, et al.

    Stroke 2023; (54(10)):e452-e464 doi:10.1161/STR.0000000000000444.

    PMID: 37602377
  7. 7

    Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) in a 32-Year-Old Male Presenting With a Transient Ischemic Attack (TIA).

    Karim R, Malik M, Cheema H, et al.

    Cureus 2024; (16(10)):e70970 doi:10.7759/cureus.70970.

    PMID: 39507177
  8. 8

    Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL): A Rare Cause of Transient Ischemic Attack.

    Ashraf S, Allena N, Shrestha E, et al.

    Cureus 2022; (14(10)):e30940 doi:10.7759/cureus.30940.

    PMID: 36465750
  9. 9

    A Report of Accelerated Coronary Artery Disease Associated with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.

    Rubin CB, Hahn V, Kobayashi T, Litwack A

    Case reports in cardiology 2015; (2015()):167513 doi:10.1155/2015/167513.

    PMID: 26435852

This comparison is for informational purposes only and does not constitute medical advice. Seek emergency help for sudden stroke symptoms, and discuss statins, blood pressure targets, and other prevention decisions with your healthcare team.

Get notified when new evidence is published on Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.